Literature DB >> 4351952

Ablation therapy for hormone-dependent tumors.

T L Dao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4351952     DOI： 10.1146/annurev.me.23.020172.000245

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN： 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  6 in total

Review 1.  [Diagnosis of irreversible loss of brain function ("brain death")-what is new?]

Authors:  Uwe Walter; Stephan A Brandt
Journal:  Nervenarzt       Date:  2019-10       Impact factor: 1.214

2.  LevoDopa test and estrogen receptor assay in prognosticating responses of patients with advanced cancer of the breast to endocrine therapy.

Authors:  G H Sasaki; B S Leung; W S Fletcher
Journal:  Ann Surg       Date:  1976-04       Impact factor: 12.969

3.  Determination and properties of proteohormone receptors in malignant gynecological tumors with special reference to lactogen receptors in human breast cancer.

Authors:  H G Bohnet
Journal:  Arch Gynecol       Date:  1980

4.  Endocrine organ metastases from breast carcinoma.

Authors:  S M de la Monte; G M Hutchins; G W Moore
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

5.  Breast cancer in a male patient with prolactinoma.

Authors:  S Haga; O Watanabe; T Shimizu; T Iida; H Imamura; T Kajiwara; M Fujibayashi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

6.  Adjuvant chemo-endocrine therapy for androgen-dependent mammary tumor in mice.

Authors:  N Uchida; K Yamaguchi; N Narita; K Nakao; Y Kitamura; K Matsumoto
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.